SPCE vs STRO
Virgin Galactic Holdings Inc (SPCE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SPCE currently screens at market cap $388.0M. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SPCE and STRO stock pages for the full models.
Not investment advice.